Techpoint
6697
FISCO
3807
NCXX Group
6634
Reyuu Japan
9425
Remixpoint
3825
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 42
- 00.00%
20min DelayTrading Jan 20 13:53 JST
3.64BMarket Cap-2.31P/E (Static)
43High42Low504.60KVolume43Open42Pre Close21.23MTurnover9052wk High0.63%Turnover Ratio86.69MShares4152wk Low-16.51EPS TTM3.39BFloat Cap2229Historical HighLossP/E (Static)80.74MShs Float41Historical Low-18.21EPS LYR2.38%Amplitude--Dividend TTM2.90P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --